Pierre Voirol
- Pharmacology top 10%
- Nutrition and Dietetics top 10%
- Epidemiology
- Pulmonary and Respiratory Medicine
- Pharmacology top 10%
- Co-authors
- Mette M. BergerPierre BaumannFarshid SadeghipourAndré PannatierA FournierPhilippe EggimannYok‐Ai QueRené Chiolero
- Topics
- Pharmaceutical Practices and Patient Outcomes (9 papers)Burn Injury Management and Outcomes (5 papers)Heart Failure Treatment and Management (4 papers)
- Partner nations
- SwitzerlandFranceUnited States
In The Last Decade
Pierre Voirol
36 papers receiving 518 citations
Peers
Comparison fields: 5 of 97
- Pharmacology 110
- Nutrition and Dietetics 101
- Epidemiology 92
- Pulmonary and Respiratory Medicine 75
- Pharmacology 59
Countries citing papers authored by Pierre Voirol
This map shows the geographic impact of Pierre Voirol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pierre Voirol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pierre Voirol more than expected).
Fields of papers citing papers by Pierre Voirol
This network shows the impact of papers produced by Pierre Voirol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pierre Voirol. The network helps show where Pierre Voirol may publish in the future.
Co-authorship network of co-authors of Pierre Voirol
This figure shows the co-authorship network connecting the top 25 collaborators of Pierre Voirol. A scholar is included among the top collaborators of Pierre Voirol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pierre Voirol. Pierre Voirol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 10 | |
| 5 | 10 | |
| 6 | 20 | |
| 7 | 19 | |
| 8 | 4 | |
| 9 | 43 | |
| 10 | 24 | |
| 11 | 7 | |
| 12 | 57 | |
| 13 | 33 | |
| 14 | 21 | |
| 15 | 4 | |
| 16 | 64 | |
| 17 | Clinical pharmacokinetics of SSRIs | 0 |
| 18 | Ultraschnelle Metabolisierer. Grundlagen und klinische Bedeutung | 0 |
| 19 | 8 | |
| 20 | 2 |
About Pierre Voirol
Pierre Voirol is a scholar working on Geriatrics and Gerontology, Applied Microbiology and Biotechnology and Family Practice, having authored 42 papers that have together received 537 indexed citations. Recurring topics across this work include Pharmaceutical Practices and Patient Outcomes (9 papers), Burn Injury Management and Outcomes (5 papers) and Heart Failure Treatment and Management (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (43 citations), Geriatrics and Gerontology (54 citations) and Family Practice (21 citations). Pierre Voirol has collaborated with scholars based in Switzerland, France and United States. Frequent co-authors include Mette M. Berger, Pierre Baumann, Farshid Sadeghipour, André Pannatier, A Fournier, Philippe Eggimann, Yok‐Ai Que, René Chiolero, A. Pannatier and Luc Tappy. Their work appears in journals such as Brain Research, Antimicrobial Agents and Chemotherapy and Molecular Psychiatry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.